Cited by 173Mitochondrial Function and PathologyMetabolism, Diabetes, and CancerBiochemical Acid Research Studies

The multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier

Open access
Zangari, Joséphine, Petrelli, Francesco, Maillot, Benoît, Martinou, Jean-Claude·2020·Biomolecules

Abstract

Pyruvate, the end product of glycolysis, plays a major role in cell metabolism. Produced in the cytosol, it is oxidized in the mitochondria where it fuels the citric acid cycle and boosts oxidative phosphorylation. Its sole entry point into mitochondria is through the recently identified mitochondrial pyruvate carrier (MPC). In this review, we report the latest findings on the physiology of the MPC and we discuss how a dysfunctional MPC can lead to diverse pathologies, including neurodegenerative diseases, metabolic disorders, and cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom10071068

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Genetic or pharmacological inhibition of the MPC in the brain affects diverse brain activities.

    “Genetic or pharmacological inhibition of the MPC in the brain has been shown to affect diverse brain activities (Buchanan and Taylor, 2020; Zangari et al., 2020).”

    From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Zangari et al., 2020

    Section 4.1 reports several effects of pharmacological MPC inhibition relevant to the brain, including neuronal protection and increased glucose uptake in affected brain regions. It does not establish comparable effects from genetic inhibition in the brain; instead, it calls for neuron- or glia-specific genetic studies to confirm the drug findings. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 103 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zangari, J., Petrelli, F., Maillot, B., & Martinou, J.-C.
Affiliations
University of Geneva (CH)
Corresponding author
Martinou, Jean-Claude
Venue
Biomolecules
Publisher
MDPI AG
Published
2020-07-17
Volume
10
Issue
7
Pages
1068
ISSN
2218-273X (ISSN-L)
OpenAlex
W3042494222
Cited by
172
References
103
Citations by year
2026: 33 · 2025: 47 · 2024: 33 · 2023: 30 · 2022: 16 · 2021: 11 · 2020: 2
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Oncosuisse (KFS-4434-02-2018)
  • Swiss National Foundation (31003A_179421)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
Keywords
pyruvate metabolism, mitochondrial pyruvate carrier, glycolysis, TCA cycle, oxidative phosphorylation, mitochondrial dysfunction, neurodegenerative diseases, metabolic disorders, cancer
MeSH terms
Animals, Gene Expression Regulation, Humans, Metabolic Diseases, Mitochondria, Neoplasms, Pyruvic Acid, Neurodegenerative Diseases, Monocarboxylic Acid Transporters, Mitochondrial Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review